Astaxanthin supplementation extracted from Haematococcus pluvialis on clinical parameters associated with chronic diseases and metabolic syndrome / Suplementação de astaxantina extraída de Haematococcus pluvialis sobre os parâmetros clínicos associados com doenças crônicas e síndrome metabólica

Authors

  • Aristeli Ferreira Altoé Brazilian Journals Publicações de Periódicos, São José dos Pinhais, Paraná
  • Carina de Aquino Paes
  • Fabiane Paula Soares da Costa Cirino
  • Amanda da Silva Franco
  • Elaine Cristina de Souza Lima
  • Paulo Rogério Melo Rodrigues
  • Patricia Coelho de Velasco
  • Felipe de Souza Cardoso

DOI:

https://doi.org/10.34117/bjdv8n1-298

Keywords:

astaxanthin, antioxidant, metabolic syndrome, oxidative stress

Abstract

Introduction: astaxanthin is a carotenoid compound found in marine organisms that, according to several studies, has significantly increased antioxidant properties, with possible benefits for the prevention and treatment of chronic diseases and metabolic syndrome. Objective: to indicate the possible biological effects of astaxanthin, as well as its forms of prescription and possible benefits for the prevention and treatment of chronic diseases and metabolic syndrome. Method: integrative review of clinical experimental studies, mainly, but of some pre-clinical studies, also published since 2000. The searches were carried out in the following databases: Pubmed, SciELO and Semantic Scholar. Results: the results indicated doses between 0.5 and 21.6mg/day, for a period from 2 weeks to 12 months, involving volunteers aged between 8 and 85 years, both genders. Supplements with astaxanthin indicated the ability to reduce oxidative stress, as well as biochemical parameters in the blood, such as low-density lipoprotein, total cholesterol, fasting glucose, triglycerides, glycated hemoglobin and others. The bioactive substance is also associated with a reduction in blood pressure, increased blood operations of high-density lipoprotein and adiponectin, reinforcing the hypothesis that astaxanthin is promising, as an aid in the prevention and treatment of chronic diseases and metabolic syndrome. Conclusion: astaxanthin appears to be a complementary and innovative element for the prevention and treatment of chronic diseases and metabolic syndrome. However, no supplement will have a “miraculous” effect and will replace with constant changes in lifestyle, including healthy eating. The antioxidant effects of astaxanthin were confirmed and associated with the most varied metabolic and clinical outcomes. However, due to the reduced amount of evidence and heterogeneity of variables, further research is needed.

References

IBGE – Pesquisa nacional de saúde: 2019: percepção do estado de saúde, estilos de vida, doenças crônicas e saúde bucal: Brasil e grandes regiões/IBGE, Coordenação de Trabalho e Rendimento. Rio de Janeiro: IBGE, 2020. 113p. Disponível em: <https://biblioteca.ibge.gov.br/visualizacao/livros/liv101764.pdf >.

ABESO. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. Mapa da obesidade. 2019. Disponível em: <https://abeso.org.br/obesidade-e-sindrome-metabolica/mapa-da-obesidade.

ABESO. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. Os últimos números da obesidade no Brasil. 2020. Disponível em: <https://abeso.org.br/os-ultimos-numeros-da-obesidade-no-brasil.

ABESO. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. Diretrizes brasileiras de obesidade/ ABESO. 2016 – 4.ed. - São Paulo, SP.

Sociedade Brasileira de Endocrinologia e Metabologia. A síndrome metabólica. 2021. Disponível em: <https://www.endocrino.org.br/a-sindrome-metabolica/>.

Sociedade Brasileira de Cardiologia (SBC). I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol. 2005. Disponível em: < http://publicacoes.cardiol.br/consenso/2005/sindromemetabolica.pdf>.

Sociedade Brasileira de Cardiologia (SBC). Diretrizes Brasileiras de Hipertensão Arterial. Arq Bras Cardiol. 2020; 116(3):516-658. Disponível em: <https://abccardiol.org/wp-content/uploads/articles_xml/0066-782X-abc-116-03-0516/0066-782X-abc-116-03-0516.x44344.pdf>.

Sociedade Brasileira de Diabetes (SBD). Diretrizes 2019-2020. Disponível em: <http://www.saude.ba.gov.br/wp-content/uploads/2020/02/Diretrizes-Sociedade-Brasileira-de-Diabetes-2019-2020.pdf>.

Sociedade Brasileira de Cardiologia (SBC). Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017; 109(2Supl.1):1-76. Doi: 10.5935/abc.20170121.

Monteiro AR, Barros LAS, Albernaz PCS, Vieira VBA, Barroso VDMP, Rodrigues MCC. Diabetes Mellitus, obesidade e maus hábitos de vida: sua relação com a Covid-19. 2020; 15(2):56-68. Doi: 10.29184/1980-7813.rcfmc.377

IDF – Internacional Diabetes Federation. IDF Diabetes Atlas. 10ed., 2021. Disponível em: <https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf>.

Rocha E. Metabolic syndrome and cardiovascular risk. Revista Portuguesa de Cardiologia. 2019; 38(5):333-5. Doi.org/10.1016/j.repc.2019.06.003

Lorenz RT, Cysewski GR. Commercial potential for Haematococcus microalgae as a natural source of astaxanthin. Trends Biotechnol. 2000; 18(4):160–7. Doi: 10.1016/s0167-7799(00)01433-5

Fasset RG, Coombes JS. Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs. 2011; 9(3):447-65. Doi: 10.3390/md9030447

Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends in Biotechnology, 2003; 21(5):210-6. Doi:10.1016/s0167-7799(03)00078-7.

Ministério da Saúde – ANVISA (Agência Nacional de Vigilância Sanitária). Instrução Normativa nº28/2018. Disponível em: <https://www.in.gov.br/materia/-/asset_publisher/Kujrw0TZC2Mb/content/id/34380639/do1-2018-07-27-instrucao-normativa-in-n-28-de-26-de-julho-de-2018-34380550>.

Conselho Federal de Nutricionistas (CFN). Resolução nº656/2020. Disponível em: <https://www.cfn.org.br/wp-content/uploads/resolucoes/DOU_656.pdf>.

Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W, Kamiyama M, Itakura H, Yamamoto S, Kondo K. Inhibition of low-density lipoprotein oxidation by astaxanthin. J Atheroscler Thromb. 2000; 7(4):216-22. Doi: 10.5551/jat1994.7.216

Karppi J, Rissanen TH, Nyyssönen K, Kaikkonen J, Olsson AG, Voutilainen S, Salonen JT. Effects of astaxanthin supplementation on lipid peroxidation. Int J Vitam Nutr Res. 2007; 77(1):3-11. Doi: 10.1024/0300-9831.77.1.3

Yoshida H, Yanai H, Ito K, Tomono Y, Koikeda T, Tsukahara H, Tada N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis. 2010; 209(2):520-3. Doi: 10.1016/j.atherosclerosis.2009.10.012

Maki KC, Geohas JG, Dicklin MR, Huebner M, Udani JK. Safety and lipid-altering efficacy of a new omega-3 fatty acid and antioxidant-containing medical food in men and women with elevated triacylglycerols. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 2015; 99(1):41–6. Doi: 10.1016/j.plefa.2015.05.002

Marazzi G, Pelliccia F, Campolongo G, Quattrino S, Cacciotti L, Volterrani M, Gaudio C, Rosano G. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease. Am J Cardiol. 2015; 116(12):1798-801. Doi: 10.1016/j.amjcard.2015.09.023

Mashhadi NS, Zakerkish M, Mohammadiasl J, Zarei M, Mohammadshahi M, Haghighizadeh MH. Astaxanthin improves glucose metabolism and reduces blood pressure in patients with type 2 diabetes mellitus. Asia Pac J Clin Nutr. 2016; 27(2):341-6. Doi: 10.6133/apjcn.052017.11

Chan K, Chen S, Chen P. Astaxanthin attenuated thrombotic risk factors in type 2 diabetic patients. Journal of Functional Foods. 2018; 53:22–7. Doi: 10.1016/j.jff.2018.12.012

Choi HD, Youn YK, Shin WG. Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects. Plant Foods Hum Nutr. 2011; 66(4):363-9. Doi: 10.1007/s11130-011-0258-9

Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011; 28(12):1105-13. Doi: 10.1007/s12325-011-0082-5

Iwabayashi M, Fujioka N, Nomoto K, et al. Efficacy and safety of eight-week treatment with astaxanthin in individuals screened for increased oxidative stress burden. Anti-Aging Medicine.2009; 6(4):15-21. Doi: 10.3793/jaam.6.15

Choi HD, Kim JH, Chang MJ, Kyu-Youn Y, Shin WG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytother Res. 2011; 25(12):1813-8. Doi: 10.1002/ptr.3494

Forti, N, Diament, J. Apolipoproteínas B e A-I: fatores de risco cardiovascular? Revista da Associação Médica Brasileira [online]. 2007; 53(3):276-82. Doi: doi.org/10.1590/S0104-42302007000300029>

Mashhadi SN, Tahmasebi M, Mohammadi-Asl J, Zakerkish M, Mohammadshahi M. The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled clinical trial. Int J Clin Pract. 2021; 75(5):e14022. Doi: 10.1111/ijcp.14022

Nakagawa K, Kiko T, Miyazawa T, Carpentero Burdeos G, Kimura F, Satoh A, Miyazawa T. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. British Journal of Nutrition. 2010; 105(11):1563–1571. Doi:10.1017/s0007114510005398

Park JS, Chyun JH, Kim YK, Line LL, Chew BP. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr Metab (Lond). 2010; 7(18):1-10. Doi: 10.1186/1743-7075-7-18

Canas JA, Lochrie A, McGowan AG, Hossain J, Schettino C, Balagopal PB. Effects of Mixed Carotenoids on Adipokines and Abdominal Adiposity in Children: A Pilot Study. J Clin Endocrinol Metab. 2017; 102(6):1983-90. Doi: 10.1210/jc.2017-00185

Birudaraju D, Cherukuri L, Kinninger A, Chaganti BT, Shaikh K, Hamal S, Budoff M J. A combined effect of Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma –linoleic acid (Omega-6) (CEAG) in healthy volunteers- a randomized, double-blind, placebo-controlled study. Clinical Nutrition ESPEN. 2019. Doi: 10.1016/j.clnesp.2019.09.011

Hussein G, Nakamura M, Zhao Q, Iguchi T, Goto H, Sankawa U, Watanabe H. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol Pharm Bull. 2005;(1):47-52. Doi: 10.1248/bpb.28.47

Hussein G, Goto H, Oda S, Sankawa U, Matsumoto K, Watanabe H. Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biol. Pharm. Touro. 2006; 29(4):684–8. Doi: 10.1248/bpb.29.684

Xu J, Rong S, Gao H, Chen C, Yang W, Deng Q, Huang, F. A Combination of Flaxseed Oil and Astaxanthin Improves Hepatic Lipid Accumulation and Reduces Oxidative Stress in High Fat-Diet Fed Rats. Nutrients. 2017; 9(3):271. Doi:10.3390/nu9030271

Uchiyama K, Naito Y, Hasegawa G, Nakamura N, Takahashi J, Yoshikawa T. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice. Redox Rep. 2002;7(5):290-3. Doi: 10.1179/135100002125000811

Arunkumar E, Bhuvaneswari S, Anuradha CV. An intervention study in obese mice with astaxanthin, a marine carotenoid – effects on insulin signaling and pro-inflammatory cytokines. Food Funct. 2012; 3(2):120–6. Doi:10.1039/c1fo10161g

Kim YJ, Kim YA, Yokozawa T. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J Agric Food Chem. 2009; 57(19):8793-7. Doi: 10.1021/jf9019745

Brabo MF, Pereira LFS, Santana JVM, Campelo DAV, Veras GC. Cenário atual da produção de pescado no mundo, no Brasil e no estado do Pará: ênfase na aquicultura. Acta of Fisheries and Aquatic Resources. 2016; 4(2):50-8. Doi: https://doi.org/10.2312/Actafish.2016.4.2.50-58

Zoboli E, Ozelka G. Conflito de interesses na pesquisa clínica. Revista Bioética. 2014;15(1):65-76.

Lima JP, Lopes CO, Dias NAA, De Angelis-Pereira MC. Atividade e Biodisponibilidade dos Carotenoides no Organismo/Activity and Bioavailability of Carotenoids in Body. Revista Ciências em Saúde.2012; 2(1):65-73. Doi: https://doi.org/10.21876/rcsfmit.v2i1.75

Wan MLY, Co VA, El-Nezami H. Dietary polyphenol impact on gut health and microbiota. Critical Reviews in Food Science and Nutrition. 2020;1–22. Doi:10.1080/10408398.2020.1744512

Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on gut microbiota and implications in human health. The Journal of Nutritional Biochemistry. 2013; 24(8):1415–22. Doi: 10.1016/j.jnutbio.2013.05.001

Santos PFCR. Neuroinflamação e a depressão. Novas abordagens terapêuticas no horizonte? Trabalho Final de Mestrado Integrado em Medicina. Faculdade de Medicina Lisboa. 2019. repositorio.ul.pt/bitstream/10451/43547/1/.

Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review. Mar Drugs. 2014; 12(1):128-52. Doi:10.3390/md12010128

IBGE – Pesquisa de orçamentos familiares 2017-2018: análise da segurança alimentar no Brasil / IBGE, Coordenação de Trabalho e Rendimento. - Rio de Janeiro: IBGE, 2020. Disponível em: <https://biblioteca.ibge.gov.br/visualizacao/livros/liv101749.pdf>.

Ministério da Saúde. Pesquisa Vigitel, 2018. Disponível em: <https://www.endocrino.org.br/media/coletiva-vigitel-2018.pdf>.

Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Guia alimentar para a população brasileira / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. 2014; 2. ed., 1. reimpr. – Brasília: Ministério da Saúde, 2014. Disponível em: <https://www.gov.br/saude/pt-br/assuntos/saude-brasil/publicacoes-para-promocao-a-saude/guia_alimentar_populacao_brasileira_2ed.pdf/view.

Downloads

Published

2022-01-17

How to Cite

Altoé, A. F., Paes, C. de A., Cirino, F. P. S. da C., Franco, A. da S., Lima, E. C. de S., Rodrigues, P. R. M., de Velasco, P. C., & Cardoso, F. de S. (2022). Astaxanthin supplementation extracted from Haematococcus pluvialis on clinical parameters associated with chronic diseases and metabolic syndrome / Suplementação de astaxantina extraída de Haematococcus pluvialis sobre os parâmetros clínicos associados com doenças crônicas e síndrome metabólica. Brazilian Journal of Development, 8(1), 4503–4527. https://doi.org/10.34117/bjdv8n1-298

Issue

Section

Original Papers